MedTrace Logo

The Comparability of Bispectral Index and Neurosense During Anesthesia

NCT00910416 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2016-09-23

No results posted yet for this study

Summary

The assessment of anesthesia depth was based, until recently, on the evolution of hemodynamic parameters. Nowadays it can be evaluated by several monitoring methods, derived from electroencephalogram analysis, namely the Bispectral Index (Aspect Medical Systems, Newton, USA). A new modality is currently under development: the NeuroSENSE (Cleveland Medical Devices Inc., Cleveland, OH 44103, USA). The goal of this study is to compare both monitoring modalities during anesthesia.

Conditions

  • Anesthesia

Interventions

DRUG

propofol, remifentanil, atracurium

propofol, remifentanil, atracurium dosages are adapted according to clinician's judgment

DRUG

propofol, remifentanil, atracurium, sevoflurane

dosages are adapted according to clinician's judgment

DEVICE

EEG monitoring

simultaneous monitoring with Bis and Neurosense

Sponsors & Collaborators

  • Hopital Foch

    lead OTHER

Principal Investigators

  • Marc Fischler, MD · Hôpital Foch

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-05-31
Primary Completion
2010-12-31
Completion
2010-12-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00910416 on ClinicalTrials.gov